Results 131 to 140 of about 18,097 (179)

Diagnostic and Prognostic Potential of CXCL9 and CXCL10 Chemokines in Alcohol-Associated Liver Disease. [PDF]

Int J Mol Sci
Szczerbinska A, Rolinski J, Surdacka A, Cichoz-Lach H.   +3 more
europepmc   +1 more source

Fibroblasts as Immunological Sentinels in Cutaneous Inflammation: A Review. [PDF]

J Clin Med
Quan T.
europepmc   +1 more source

The Importance of Chemokines Activating CXCR1, CXCR2 and CXCR3 in Tumorigenesis as Potential Therapeutic Targets in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. [PDF]

Cancers (Basel)
Korbecki J, Barczak K, Bosiacka B, Surówka A, Duchnik E, Skarbiński M, Snarski E, Chlubek D, Bosiacki M.   +8 more
europepmc   +1 more source

Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment. [PDF]

Nat Commun
Krossa S, Andersen MK, Sandholm EM, Wess M, Kiviaho A, Sharma A, Hakkola S, Hao Y, Alshalalfa M, Davicioni E, Viset T, Størkersen Ø, Karnes RJ, Spratt DE, Giskeødegård GF, Nykter M, Rye MB, Urbanucci A, Tessem MB.   +18 more
europepmc   +1 more source

Correction: A novel disulfidptosis-related mRNA signature predicts prognosis and therapeutic response in lung squamous cell carcinoma. [PDF]

BMC Pulm Med
Bai W, Jiang N, Deng Y, Tang X, Zhang F, Niu S, Yao Y, Zhou Y, Chen K, Li L, Yang J, Lv XB.   +11 more
europepmc   +1 more source

The N-terminal ELR⁺ motif of the neutrophil attractant CXCL8 confers susceptibility to degradation by the Group A streptococcal protease, SpyCEP. [PDF]

J Biol Chem
Giblin SP, McKenna S, Matthews S, Sriskandan S, Pease JE.   +4 more
europepmc   +1 more source

Functional Interactions Between Recombinant Serum Amyloid A1 (SAA1) and Chemokines in Leukocyte Recruitment. [PDF]

Int J Mol Sci
Van Damme J, Struyf S, Proost P, Opdenakker G, Gouwy M.   +4 more
europepmc   +1 more source

CXCR4 expression serves as a promising candidate target in the treatment of breast cancer. [PDF]

Medicine (Baltimore)
Liao F, Huang J, Zhang Y.
europepmc   +1 more source

Dual-faced CXCL5 holds the key to unlocking immunotherapy in obese pancreatic cancer. [PDF]

J Immunother Cancer
Liang L, Zhou Y, Liu L.
europepmc   +1 more source